Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Product containing precisely docosanol 100 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Is a |
Product containing docosanol (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Product containing precisely docosanol 100 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Behenic acid |
false |
Inferred relationship |
Some |
|
|
Product containing precisely docosanol 100 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
forme pharmaceutique pour usage transdermique et/ou cutané |
false |
Inferred relationship |
Some |
|
|
Product containing precisely docosanol 100 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. |
false |
Inferred relationship |
Some |
|
|
Product containing precisely docosanol 100 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Docosanol (substance) |
false |
Inferred relationship |
Some |
|
|
Product containing precisely docosanol 100 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
Cutaneous cream |
true |
Inferred relationship |
Some |
|
|
Product containing precisely docosanol 100 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Is a |
Product manufactured as cutaneous dose form (product) |
false |
Inferred relationship |
Some |
|
|
Product containing precisely docosanol 100 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Some |
|
|
Product containing precisely docosanol 100 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Count of base of active ingredient |
un |
false |
Inferred relationship |
Some |
|
|
Product containing precisely docosanol 100 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
This attribute specifies the numerator unit for the concentration strength of a product. |
mg |
true |
Inferred relationship |
Some |
1 |
|
Product containing precisely docosanol 100 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Docosanol (substance) |
true |
Inferred relationship |
Some |
1 |
|
Product containing precisely docosanol 100 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has concentration strength numerator value |
10^2 |
false |
Inferred relationship |
Some |
1 |
|
Product containing precisely docosanol 100 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has concentration strength denominator value |
un |
false |
Inferred relationship |
Some |
1 |
|
Product containing precisely docosanol 100 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
This attribute specifies the denominator unit for the concentration strength of a product. |
mL |
true |
Inferred relationship |
Some |
1 |
|
Product containing precisely docosanol 100 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Docosanol (substance) |
true |
Inferred relationship |
Some |
1 |
|
Product containing precisely docosanol 100 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Is a |
Docosanol only product in cutaneous dose form |
true |
Inferred relationship |
Some |
|
|
Product containing precisely docosanol 100 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Plays role |
Antiviral therapeutic role |
false |
Inferred relationship |
Some |
|
|